Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Synonyms :
Class :
Brand Name :
Synonyms :
Class :
Systemic Lupus Erythematosus (SLE)Â
Indicated for the above condition in people who are already receiving a therapy
Intravenous
10 mg/kg intravenously every 2 weeks multiplied by 3 doses
Maintenance dose- 10 mg/kg intravenously every month
Subcutaneous
200 mg subcutaneously every week
If changing from intravenous to subcutaneous dose, administer the 1st subcutaneous dose 7-28 days later and the last intravenous dose
Indicated for the above condition in people who are already receiving a therapy
Intravenous
10 mg/kg intravenously every 2 weeks multiplied by 3 doses
Maintenance dose- 10 mg/kg intravenously every month
Subcutaneous
400 mg dose initially (divided into 2 injections) subcutaneously every week multiplied by 4 doses
Maintenance dose- 200 mg subcutaneously every week
belimumab's immunosuppressive properties reduce the efficacy of the live rotavirus oral vaccine, leading to diminished effects
belimumab's immunosuppressive properties reduce the efficacy of the live rotavirus oral vaccine, leading to diminished effects
belimumab's immunosuppressive properties reduce the efficacy of the live rotavirus oral vaccine, leading to diminished effects
belimumab's immunosuppressive properties reduce the efficacy of the live rotavirus oral vaccine, leading to diminished effects
belimumab's immunosuppressive properties reduce the efficacy of the live rotavirus oral vaccine, leading to diminished effects
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
it may reduce the therapeutic effect of covid-19 vaccines 
may increase the risk of toxic effects when combined
may increase the risk or severity of adverse effects when combined
may decrease the therapeutic effect of COVID-19 vaccine
may enhance the risk of adverse effect when combined with belimumab
may increase the immunosuppressive effect of anti-psoriatic agents
human papillomavirus vaccine, nonavalentÂ
may diminish the effect of each other when combined
by suppressing the immune system, belimumab lessens the effects of the influenza A (H5N1) vaccination
pneumococcal vaccine polyvalentÂ
the effect of pneumococcal vaccine polyvalent may be reduced due to immunosuppressive effects
pneumococcal vaccine 13-valentÂ
belimumab diminishes the efficacy of the 13-valent pneumococcal vaccine due to its immunosuppressive effects, thereby increasing the risk of infection
may enhance the immunosuppressive effects of DMARDs
in combination with ofatumumab, belimumab increases the risk of adverse events.
it may increase the immunosuppressive effect of biologic disease-modifying antirheumatic agents 
may increase the immunosuppressive effect
may increase the immunosuppressive effect
may have an increased immunosuppressive effect when combined with disease-modifying antirheumatic drugs
may have an increased immunosuppressive effect when combined with disease-modifying antirheumatic drugs
it may enhance the adverse effects when combined with aducanumab
it may enhance the risk of side effects when combined with mitomycin
When mometasone furoate is used together with belimumab, this leads to enhanced risk or seriousness of adverse outcomes
poliovirus vaccine inactivatedÂ
because belimumab has immunosuppressive properties, it lessens the effects of the poliovirus vaccine inactivated
antithymocyte globulin rabbitÂ
the risk or extent of adverse effects can be raised when anti-thymocyte immunoglobulin (rabbit) is combined with belatacept
By immunosuppressive effects, the both the drugs action either decreases and results in risk of infection.
may increase the risk or severity of infection when combined
It may enhance the adverse effects when combined with sotrovimab
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
